07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
Perhaps this is an indication of the way things are going to be after Brexit. The Governments of Ger...
Read More >
On July 25, 2019, active Governor Sheila Oliver signed a law that bans employers from asking job app...
Read More >
Over the past few years, many manufacturing industries have faced a new trend: reseller (i.e., distr...
Read More >
The litigator's secret weapon: good manners. William Hanson, the etiquette columnist for the Daily ...
Read More >
The Burns & Levinson 2019 State of the Cannabis Industry Conference concluded with a final panel, co...
Read More >
If you do not follow the Oregon legislature closely, you may have missed a new law, which went into ...
Read More >